part 3 election impact
healthcare ballot
democratic party
flagship expansionary
balanced senate
narrow senate
pricing reduction
surprise billing
bipartisan support
lower reimbursement
biopharma impact
stakeholder priorities
connect with us

An overview of key policies and additional details on overall feasibility by election outcome have been summarized in these supplemental materials

From the senior members of the U.S. L.E.K. Consulting Healthcare Services team:

Wiley Bell, Managing Director
Max Cambras, Managing Director
Kevin Grabenstatter, Managing Director
Jonathan Kfoury, Managing Director 
Rosie Jiang, Global Healthcare Specialist
Max Reik, Senior Associate Consultant
Sam Rude, Senior Associate Consultant

Please reach out to us if you would like to continue the discussion.

Related Insights